IGC Expanding Clinical Trials Of THC Based Drug Following Approval From Health Canada
India Globalization Capital, Inc. (AMEX:IGC) has received a no objection letter from Health Canada for approval of its trial, “A phase 2, multi-center, double-blind, randomized, placebo-controlled trial of the safety and efficacy of IGC-AD1 on agitation in participants wi
